# FreeFlow Percutaneous Atrial Septal Shunt for IPAH

> **NCT06605794** · NA · RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DEVICE:** FreeFlow percutaneous atrial septal shunt

## Key facts

- **NCT ID:** NCT06605794
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-11
- **Primary completion:** 2027-09-11
- **Final completion:** 2027-09-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06605794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06605794, "FreeFlow Percutaneous Atrial Septal Shunt for IPAH". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06605794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*